{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:18:59Z","timestamp":1790486339745,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.intimp.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T08:46:12Z","timestamp":1400057172000},"page":"208-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock"],"prefix":"10.1016","volume":"21","author":[{"given":"Alexander B.","family":"Sigalov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.05.001_bb0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/14728214.12.3.449","article-title":"Emerging drugs for non-small-cell lung cancer","volume":"12","author":"Felip","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.intimp.2014.05.001_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.intimp.2014.05.001_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0020","first-page":"101","article-title":"Tumor-associated macrophage: its role in cancer invasion and metastasis","volume":"2","author":"Shih","year":"2006","journal-title":"J Cancer Mol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0025","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1200\/JCO.2005.01.4910","article-title":"Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer","volume":"23","author":"Welsh","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jlb.64.3.275","article-title":"Tumor-induced immune dysfunction: the macrophage connection","volume":"64","author":"Elgert","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000093002","article-title":"Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF \u2014 an independent prognostic factor","volume":"70","author":"Kaminska","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.intimp.2014.05.001_bb0040","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2014.05.001_bb0045","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2014.05.001_bb0050","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00024382-199610001-00007","article-title":"Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis","volume":"6","author":"Ayala","year":"1996","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2014.05.001_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1542\/peds.108.2.329","article-title":"Association between serum macrophage colony-stimulating factor levels and monocyte and thrombocyte counts in healthy, hypoxic, and septic term neonates","volume":"108","author":"Oren","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.intimp.2014.05.001_bb0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/315214","article-title":"Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options","volume":"181","author":"Gogos","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2014.05.001_bb0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/35074114","article-title":"TREM-1 amplifies inflammation and is a crucial mediator of septic shock","volume":"410","author":"Bouchon","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2014.05.001_bb0070","first-page":"1561","article-title":"Effects of the TREM-1 pathway modulation during empyema in rats","volume":"123","author":"Luo","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.intimp.2014.05.001_bb0075","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/art.24554","article-title":"Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis","volume":"60","author":"Murakami","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2014.05.001_bb0080","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1172\/JCI30602","article-title":"TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases","volume":"117","author":"Schenk","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2014.05.001_bb0085","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.180.5.3520","article-title":"Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide","volume":"180","author":"Dower","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0090","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.200704-641OC","article-title":"TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer","volume":"177","author":"Ho","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2014.05.001_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1746-1596-8-24","article-title":"Triggering receptor expressed on myeloid cells-1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis","volume":"8","author":"van Bremen","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/cc3732","article-title":"Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis","volume":"9","author":"Gibot","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.intimp.2014.05.001_bb0105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/eji.200636387","article-title":"TREM-1 promotes survival during septic shock in mice","volume":"37","author":"Gibot","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cellimm.2011.10.006","article-title":"Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis","volume":"272","author":"Wang","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/SHK.0b013e3181a53842","article-title":"Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats","volume":"32","author":"Gibot","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2014.05.001_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.intimp.2013.06.009","article-title":"TREM-1 inhibition attenuates inflammation and tumor within the colon","volume":"17","author":"Zhou","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2006.08.004","article-title":"Immune cell signaling: a novel mechanistic model reveals new therapeutic targets","volume":"27","author":"Sigalov","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.intimp.2014.05.001_bb0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0021-9673(01)88920-2","article-title":"Large-scale isolation and purification of human apolipoproteins A-I and A-II","volume":"537","author":"Sigalov","year":"1991","journal-title":"J Chromatogr"},{"key":"10.1016\/j.intimp.2014.05.001_bb0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0014-5793(98)00908-9","article-title":"Enzymatic repair of oxidative damage to human apolipoprotein A-I","volume":"433","author":"Sigalov","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.intimp.2014.05.001_bb0140","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2014.05.001_bb0145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1194\/jlr.D500033-JLR200","article-title":"Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B","volume":"47","author":"Oda","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.intimp.2014.05.001_bb0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0009-3084(01)00186-4","article-title":"Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles","volume":"113","author":"Sigalov","year":"2001","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.intimp.2014.05.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/cmmi.1587","article-title":"Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages","author":"Sigalov","year":"2014","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.intimp.2014.05.001_bb0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/CAD.0b013e3282f1da86","article-title":"Evaluation of synthetic\/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel","volume":"19","author":"McConathy","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.intimp.2014.05.001_bb0165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-2697(78)90586-9","article-title":"A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples","volume":"87","author":"Markwell","year":"1978","journal-title":"Anal Biochem"},{"key":"10.1016\/j.intimp.2014.05.001_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0003-2697(87)90649-X","article-title":"Inorganic and organic phosphate measurements in the nanomolar range","volume":"161","author":"Van Veldhoven","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.intimp.2014.05.001_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2014.05.001_bb0180","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","article-title":"Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials","volume":"84","author":"Johnson","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2014.05.001_bb0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cmmi.257","article-title":"Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis","volume":"3","author":"Chen","year":"2008","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.intimp.2014.05.001_bb0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/10717544.2013.819611","article-title":"Oral delivery of therapeutic proteins and peptides: a review on recent developments","volume":"20","author":"Gupta","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.intimp.2014.05.001_bb0195","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI104625","article-title":"Further characterization of the human serum D 1.063-1.21, alpha-lipoprotein","volume":"41","author":"Scanu","year":"1962","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2014.05.001_bb0200","first-page":"193","article-title":"Studies of the metabolism of radioiodinated human serum alpha lipoprotein in normal and hyperlipidemic subjects","volume":"63","author":"Furman","year":"1964","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.intimp.2014.05.001_bb0205","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20040708","article-title":"A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis","volume":"200","author":"Gibot","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2014.05.001_bb0210","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/IAI.74.5.2823-2830.2006","article-title":"Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock","volume":"74","author":"Gibot","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2014.05.001_bb0215","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0220","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.170.7.3812","article-title":"A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response","volume":"170","author":"Bleharski","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.imlet.2007.11.021","article-title":"The TREM-1\/DAP12 pathway","volume":"116","author":"Tessarz","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.intimp.2014.05.001_bb0230","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0235","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3748\/wjg.v10.i18.2744","article-title":"Expression of TREM-1 mRNA in acute pancreatitis","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0240","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.it.2004.08.009","article-title":"Multichain immune recognition receptor signaling: different players, same game?","volume":"25","author":"Sigalov","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0245","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1021\/bi035900h","article-title":"Homooligomerization of the cytoplasmic domain of the T cell receptor \u03b6 chain and of other proteins containing the immunoreceptor tyrosine-based activation motif","volume":"43","author":"Sigalov","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2014.05.001_bb0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.pbiomolbio.2011.08.005","article-title":"Uncoupled binding and folding of immune signaling-related intrinsically disordered proteins","volume":"106","author":"Sigalov","year":"2011","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0255","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbamcr.2006.04.013","article-title":"Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function","volume":"1763","author":"Amon","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.intimp.2014.05.001_bb0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000053639","article-title":"T cell receptor mimic peptides and their potential application in T-cell-mediated disease","volume":"123","author":"Enk","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0265","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/14728222.12.6.677","article-title":"Novel mechanistic concept of platelet inhibition","volume":"12","author":"Sigalov","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.intimp.2014.05.001_bb0270","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1172\/JCI23956","article-title":"HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation","volume":"115","author":"Quintana","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2014.05.001_bb0275","doi-asserted-by":"crossref","first-page":"e1000404","DOI":"10.1371\/journal.ppat.1000404","article-title":"Novel mechanistic insights into viral modulation of immune receptor signaling","volume":"5","author":"Sigalov","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.intimp.2014.05.001_bb0280","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/cbic.201300191","article-title":"The topology, in model membranes, of the core peptide derived from the T-cell receptor transmembrane domain","volume":"14","author":"Matalon","year":"2013","journal-title":"Chembiochem"},{"key":"10.1016\/j.intimp.2014.05.001_bb0285","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0076-6879(86)28092-1","article-title":"Reconstitution of high-density lipoproteins","volume":"128","author":"Jonas","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0290","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425247.4.6.665","article-title":"Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs","volume":"4","author":"Lacko","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.intimp.2014.05.001_bb0295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/ATVBAHA.108.179275","article-title":"High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis","volume":"30","author":"Skajaa","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.intimp.2014.05.001_bb0300","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1046\/j.1432-1327.2001.02253.x","article-title":"Human neutrophils employ the myeloperoxidase\/hydrogen peroxide\/chloride system to oxidatively damage apolipoprotein A-I","volume":"268","author":"Bergt","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.intimp.2014.05.001_bb0305","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000348283","article-title":"Prognostic value and therapeutic potential of TREM-1 in Streptococcus pyogenes-induced sepsis","volume":"5","author":"Horst","year":"2013","journal-title":"J Innate Immun"},{"key":"10.1016\/j.intimp.2014.05.001_bb0310","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.193.6.727","article-title":"Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy","volume":"193","author":"Lin","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2014.05.001_bb0315","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1158\/0008-5472.CAN-04-0961","article-title":"Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice","volume":"64","author":"Aharinejad","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2014.05.001_bb0320","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1136\/ard.2011.152769","article-title":"Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register","volume":"70","author":"Galloway","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2014.05.001_bb0325","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1995.03520360048038","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group","volume":"273","author":"Abraham","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2014.05.001_bb0330","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","article-title":"Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis","volume":"166","author":"Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2014.05.001_bb0335","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2014.05.001_bb0340","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2014.05.001_bb0345","doi-asserted-by":"crossref","first-page":"720865","DOI":"10.1155\/2012\/720865","article-title":"TREM-1 promotes pancreatitis-associated intestinal barrier dysfunction","volume":"2012","author":"Dang","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.intimp.2014.05.001_bb0350","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.CCM.0B013E318161FAF3","article-title":"Effects of the TREM-1 pathway modulation during mesenteric ischemia\u2013reperfusion in rats","volume":"36","author":"Gibot","year":"2008","journal-title":"Crit Care Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T08:49:20Z","timestamp":1565426960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914001714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1567576914001714"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.05.001","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}